/
ABOUT MOLINA HEALTHCARE Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces (the Marketplace ). Molina was founded in 1980 as a provider organization serving low-income families in Southern California and reincorporated in Delaware in 2002.
$225.37
+$0.55 (+0.24%)
EOD Jul 17, 2026
Operating margin is thin at 1.72%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 11.7%, still solid. Margins contracted 2.5pp, which offsets some of the top-line progress.
At 25x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 217% versus the prior year, cash generation momentum has weakened.
25.3x earnings. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$45.43B
▲ +11.7% YoY
Net Income (TTM)
$472M
▼ -60.0% YoY
Op. Margin
1.72%
▼ -2.5pp YoY
ROIC
8.39%
▼ -9.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$636M
▼ -216.9% YoY
Op. Cash Flow (TTM)
-$535M
▼ -183.1% YoY
Net Debt
-$4.21B
Net Cash Position
Cash & Equiv.
$8.26B
5Y CAGR: +18.5%
Continue Research
At a P/E of 25.3, Molina Healthcare (MOH)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Molina Healthcare scores 48/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Molina Healthcare scores 48 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 1.7% operating margin and a 8.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh MOH's valuation and scores 48/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.